HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K M Kendrick Selected Research

CHF 2819

8/2001Effects of ENA713 and CHF2819, two anti-Alzheimer's disease drugs, on rat amino acid levels.
7/2000Biochemical and neurobehavioral profile of CHF2819, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K M Kendrick Research Topics

Disease

4Alzheimer Disease (Alzheimer's Disease)
07/2007 - 05/2000
1Mental Disorders (Mental Disorder)
01/2013
1Anxiety Disorders (Anxiety Disorder)
11/2010
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
11/2010
1Neurodegenerative Diseases (Neurodegenerative Disease)
03/2009
1Cognitive Dysfunction
07/2000
1Amnesia (Dissociative Amnesia)
07/2000
1Depressive Disorder (Melancholia)
07/2000
1Body Weight (Weight, Body)
07/2000

Drug/Important Bio-Agent (IBA)

2CHF 2819IBA
08/2001 - 07/2000
2Rivastigmine (Exelon)FDA LinkGeneric
08/2001 - 05/2000
2Cholinesterase Inhibitors (Anticholinesterases)IBA
08/2001 - 07/2000
1Propranolol (Inderal)FDA LinkGeneric
11/2010
1Norepinephrine (Noradrenaline)FDA LinkGeneric
11/2010
1Estradiol (Delestrogen)FDA LinkGeneric
03/2009
1Estrogens (Estrogen)FDA Link
03/2009
1OzoneIBA
03/2009
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2007
1Amyloid beta-PeptidesIBA
07/2007
1Amino AcidsFDA Link
08/2001
1Scopolamine (Hyoscine)FDA Link
07/2000
1Cholinergic Agents (Cholinergics)IBA
07/2000
1Neurotransmitter Agents (Neurotransmitter)IBA
05/2000

Therapy/Procedure

1Therapeutics
01/2013
1Secondary Prevention
11/2010